136 related articles for article (PubMed ID: 17636279)
1. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity.
Kevenaar ME; Themmen AP; Rivadeneira F; Uitterlinden AG; Laven JS; van Schoor NM; Lips P; Pols HA; Visser JA
Hum Reprod; 2007 Sep; 22(9):2382-8. PubMed ID: 17636279
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.
Kevenaar ME; Themmen AP; Laven JS; Sonntag B; Fong SL; Uitterlinden AG; de Jong FH; Pols HA; Simoni M; Visser JA
Hum Reprod; 2007 Jun; 22(6):1547-54. PubMed ID: 17337470
[TBL] [Abstract][Full Text] [Related]
3. Genes involved in initial follicle recruitment may be associated with age at menopause.
Voorhuis M; Broekmans FJ; Fauser BC; Onland-Moret NC; van der Schouw YT
J Clin Endocrinol Metab; 2011 Mar; 96(3):E473-9. PubMed ID: 21193543
[TBL] [Abstract][Full Text] [Related]
4. Association study of anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.
Yoon SH; Choi YM; Hong MA; Kim JJ; Lee GH; Hwang KR; Moon SY
Hum Reprod; 2013 Dec; 28(12):3301-5. PubMed ID: 24146295
[TBL] [Abstract][Full Text] [Related]
5. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
[TBL] [Abstract][Full Text] [Related]
6. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
[TBL] [Abstract][Full Text] [Related]
7. AMH and AMHR2 polymorphisms and AMH serum level can predict assisted reproduction outcomes: a cross-sectional study.
Peluso C; Fonseca FL; Gastaldo GG; Christofolini DM; Cordts EB; Barbosa CP; Bianco B
Cell Physiol Biochem; 2015; 35(4):1401-12. PubMed ID: 25790842
[TBL] [Abstract][Full Text] [Related]
8. Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause.
Zerbetto I; Gromoll J; Luisi S; Reis FM; Nieschlag E; Simoni M; Petraglia F
Fertil Steril; 2008 Dec; 90(6):2264-8. PubMed ID: 18178196
[TBL] [Abstract][Full Text] [Related]
9. Interactions between genetic variants in AMH and AMHR2 may modify age at natural menopause.
Braem MG; Voorhuis M; van der Schouw YT; Peeters PH; Schouten LJ; Eijkemans MJ; Broekmans FJ; Onland-Moret NC
PLoS One; 2013; 8(3):e59819. PubMed ID: 23544102
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
[TBL] [Abstract][Full Text] [Related]
11. Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
Freeman EW; Gracia CR; Sammel MD; Lin H; Lim LC; Strauss JF
Fertil Steril; 2007 Jan; 87(1):101-6. PubMed ID: 17109858
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane.
Gigli I; Cushman RA; Wahl CM; Fortune JE
Mol Reprod Dev; 2005 Aug; 71(4):480-8. PubMed ID: 15895366
[TBL] [Abstract][Full Text] [Related]
13. AMH and AMHR2 genetic variants in Chinese women with primary ovarian insufficiency and normal age at natural menopause.
Qin C; Yuan Z; Yao J; Zhu W; Wu W; Xie J
Reprod Biomed Online; 2014 Sep; 29(3):311-8. PubMed ID: 24912417
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between AMH and AMHR2 Polymorphisms and the Follicular Phase in Late Reproductive Stage Women.
Jurczak A; Szkup M; Grzywacz A; Safranow K; Grochans E
Int J Environ Res Public Health; 2016 Feb; 13(2):185. PubMed ID: 26848671
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
Georgopoulos NA; Karagiannidou E; Koika V; Roupas ND; Armeni A; Marioli D; Papadakis E; Welt CK; Panidis D
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
[TBL] [Abstract][Full Text] [Related]
16. Three novel AMH gene mutations in a patient with persistent mullerian duct syndrome and normal AMH serum dosage.
Menabò S; Balsamo A; Nicoletti A; Gennari M; Pirazzoli P; Cicognani A; Baldazzi L
Horm Res; 2008; 70(2):124-8. PubMed ID: 18547961
[TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause.
La Marca A; De Leo V; Giulini S; Orvieto R; Malmusi S; Giannella L; Volpe A
J Soc Gynecol Investig; 2005 Oct; 12(7):545-8. PubMed ID: 16046154
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of anti-Müllerian hormone signaling pathway in healthy Singapore women: population differences, endocrine effects and reproductive outcomes.
Yu ED; Zhu H; Li Y; Chua SE; Indran IR; Li J; Yong EL
Gynecol Endocrinol; 2016; 32(4):311-4. PubMed ID: 26633196
[TBL] [Abstract][Full Text] [Related]
19. Body mass index but not a polymorphism of the interleukin-1 receptor antagonist (IL-1 RA) gene is associated with age at natural menopause.
Riener EK; Keck C; Worda C; Hefler LA; Tempfer CB
Gynecol Obstet Invest; 2004; 58(2):117-20. PubMed ID: 15205567
[TBL] [Abstract][Full Text] [Related]
20. The influence of Nos3 polymorphisms on age at menarche and natural menopause.
Worda C; Walch K; Sator M; Eppel W; Tempfer CB; Schneeberger C; Huber JC; Hefler LA
Maturitas; 2004 Oct; 49(2):157-62. PubMed ID: 15474760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
